LETTER
Booth, C. L. J.; Herrmann, S. M.; Ward, R. W.; White, J.;
Synthesis of Unsymmetrical Diaryl Sulfones
1167
A.; Lo, W. F.; Kaiser, H. M.; Beller, M.; Tse, M. K. Org.
Lett. 2007, 9, 3405. (i) Huang, F.; Batey, R. A. Tetrahedron
2007, 63, 7667. (j) Bian, M.; Xu, F.; Ma, C. Synthesis 2007,
2951. (k) Reeves, D. C.; Rodriguez, S.; Heewon, L.;
Haddad, N.; Krishnamurthy, D.; Senayake, C. H.
Tetrahedron Lett. 2009, 50, 2870.
Bartlett, C. A.; Morse, C. A. J. Med. Chem. 1997, 40, 677.
(d) Dinsmore, C. J.; Williams, T. M.; O’Neill, T. J.; Liu, D.;
Rands, E.; Culberson, J. C.; Lobell, R. B.; Koblan, K. S.;
Kohl, N. E.; Gibbs, J. B.; Oliff, A. I.; Graham, S. L.;
Hartman, G. D. Bioorg. Med. Chem. Lett. 1999, 9, 3301.
(e) Sun, Z. Y.; Botros, E.; Su, A. D.; Kim, Y.; Wang, E.;
Baturay, N. Z.; Kwon, C. H. J. Med. Chem. 2000, 43, 4160.
(f) Doherty, G. A.; Kamenecka, T.; McCauley, E.; Van
Riper, G.; Mumford, R. A.; Tonga, S.; Hagmanna, W. K.
Bioorg. Med. Chem. Lett. 2002, 12, 729. (g) Pal, M.;
Veeramaneni, V. R.; Nagabelli, M.; Kalleda, S. R.; Misra,
P.; Casturib, S. R.; Yeleswarapua, K. R. Bioorg. Med. Chem.
Lett. 2003, 13, 1639. (h) Otzen, T.; Wempe, E. G.; Kunz, B.;
Bartels, R.; Lehwark-Yvetot, G.; Hänsel, W.; Schaper, K. J.;
Seydel, J. K. J. Med. Chem. 2004, 47, 240. (i) Hartz, R. A.;
Arvanitis, A. G.; Arnold, C.; Rescinito, J. P.; Hung, K. L.;
Zhang, G.; Wong, H.; Langley, D. R.; Gilligan, P. J.;
Trainor, G. L. Bioorg. Med. Chem. Lett. 2006, 16, 934.
(2) (a) Aldea, R.; Alper, H. J. Org. Chem. 1995, 60, 8365.
(b) Reddy, T. I.; Varma, R. S. Chem. Commun. 1997, 5, 471.
(c) Al-Maksoud, W.; Daniele, S.; Sorokin, A. B. Green
Chem. 2008, 10, 447. (d) Rahimizadeh, M.; Rajabzadeh, G.;
Khatami, S. M.; Eshghi, H.; Shiri, A. J. Mol. Catal. A:
Chem. 2010, 323, 59. (e) Rostami, A.; Akradi, J.
(5) (a) Ballini, R.; Marcantoni, E.; Petrin, M. Tetrahedron 1989,
45, 6791. (b) Kamijo, S.; Al-Masum, M.; Yamamoto, Y.
Tetrahedron Lett. 1998, 39, 691. (c) Taniguchi, T.; Idota, A.;
Ishibashi, H. Org. Biomol. Chem. 2011, 9, 3151. (d) Li, X.;
Xu, X.; Zhou, C. Chem. Commun. 2012, 48, 12240.
(6) (a) Liu, B.; Li, J.; Song, F. J.; You, J. S. Chem. Eur. J. 2012,
18, 10830. (b) Yu, X. Z.; Li, X. W.; Wan, B. S. Org. Biomol.
Chem. 2012, 10, 7479. (c) Yang, F. L.; Ma, X. T.; Tian, S.
K. Chem. Eur. J. 2012, 18, 1582. (d) Yuen, O. Y.; So, C. M.;
Wong, W. T.; Kwong, F. Y. Synlett 2012, 23, 2714.
(7) (a) Yang, F. L.; Tian, S. K. Angew. Chem. Int. Ed. 2013, 125,
5029. (b) Singh, N.; Singh, R.; Raghuvanshi, D. S.; Singh,
K. N. Org. Lett. 2013, 15, 5874.
(8) Beaulieu, C.; Guay, D.; Wang, Z. Y.; Evans, D. A.
Tetrahedron Lett. 2004, 45, 3233.
(9) General Procedure
Arylboronic acids (1.2 mmol), arylsulfonyl hydrazides (1.0
mmol), cupric acetate (1.5 mmol), and EtOH (2.0 mL) were
taken in a 25 mL two-neck flask. The reaction mixture was
stirred at r.t. for 6 h in air. The solution was evaporated under
reduced pressure and H2O (20 mL) was added, and then the
mixture was extracted with EtOAc (4 10 mL). The extracts
were combined and washed with brine (3 10 mL), dried over
MgSO4, filtered, evaporated, and purified by chromatog-
raphy on silica gel to obtain the desired products with
EtOAc–hexane (v/v = 1:5 to 1:10). The products were
characterized by their spectral and analytical data and
compared with those of the known compounds (see
Supporting Information).
Tetrahedron Lett. 2010, 51, 3501.
(3) (a) Graybill, B. M. J. Org. Chem. 1967, 32, 2931. (b) Ueda,
M.; Uchiyama, K.; Kano, T. Synthesis 1984, 323.
(c) Choudary, B. M.; Chowdari, N. S.; Kantam, M. L.
J. Chem. Soc., Perkin Trans 2000, 1, 2689. (d) Nara, S. J.;
Harjani, J. R.; Salunkhe, M. M. J. Org. Chem. 2001, 66,
8616. (e) Frost, C. G.; Hartley, J. P.; Whittle, A. J. Synlett
2001, 830. (f) Bandgar, B. P.; Kasture, S. P. Synth. Commun.
2001, 31, 1065.
(4) (a) Suzuki, H.; Abe, H. Tetrahedron Lett. 1995, 36, 6239.
(b) Baskin, J. M.; Wang, Z. Org. Lett. 2002, 4, 4423.
(c) Cacchi, S.; Fabrizi, G.; Goggiamani, A.; Parisi, L. M.
Org. Lett. 2002, 4, 4719. (d) Cacchi, S.; Fabrizi, G.;
Goggiamani, A.; Parisi, L. M. Synlett 2003, 361. (e) Cacchi,
S.; Fabrizi, G.; Goggiamani, A.; Parisi, L. M.; Bernini, R.
J. Org. Chem. 2004, 69, 5608. (f) Bandgar, B. P.; Bettigeri,
S. V.; Phopase, J. Org. Lett. 2004, 13, 2105. (g) Zhu, W.;
Ma, D. J. Org. Chem. 2005, 70, 2696. (h) Kar, A.; Sayyed, I.
Typical Data for Representative Compound: p-Ethyl-
phenyl p-Tolyl Sulfone (Table 2, Entry 4)
1H NMR (300 MHz, CDCl3): δ = 7.85–7.81 (m, 4 H), 7.31–
7.27 (m, 4 H), 2.68–2.66 (m, 2 H), 2.38 (s, 3 H), 1.22 (m, 3
H). 13C NMR (75 MHz, CDCl3): δ = 144.0, 139.1, 139.0,
129.9, 128.7, 127.6, 28.8, 21.6, 15.1. GC–MS (EI): m/z =
260 [M+]. Anal Calcd for C15H16O2S C: 69.20; H, 6.19.
Found: C, 69.12; H, 6.15.
© Georg Thieme Verlag Stuttgart · New York
Synlett 2014, 25, 1163–1167